UroGen Pharma Ltd. (URGN) revenue

Revenue · fiscal 2025
$109.79M

UroGen Pharma Ltd. (URGN) reported revenue of $109.79M in fiscal 2025 (the year ended December 31, 2025). That is 21.4% higher than the $90.40M of fiscal 2024. Figures as of 18 Nov 2026, 12:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$109.79M
Change on fiscal 2024
+21.4%
Growth, 5 years
+56.2% a year
Highest on record
$109.79Mfiscal 2025
Lowest on record
$18.00Kfiscal 2019
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

UroGen Pharma Ltd. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 56.2% a year. Across the 10 fiscal years on record (2016–2025), the highest was $109.79M in fiscal 2025 and the lowest $18.00K in fiscal 2019.

History · 10 fiscal years

Revenue by fiscal year

UroGen Pharma Ltd. revenue, year by year

UroGen Pharma Ltd. (URGN) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$109.79M 21.4% up
2024$90.40M 9.3% up
2023$82.71M 28.5% up
2022$64.36M 34.0% up
2021$48.04M 307.2% up
2020$11.80M 65,450.0% up
2019$18.00K 98.4% down
2018$1.13M 86.2% down
2017$8.16M 53.5% down
2016$17.53M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on URGN

UroGen Pharma Ltd., figure by figure

UroGen Pharma Ltd. (URGN) overview: price, valuation and scorecard

UroGen Pharma Ltd. revenue: questions and answers

What is UroGen Pharma Ltd.'s revenue?

UroGen Pharma Ltd. (URGN) reported revenue of $109.79M in fiscal 2025 (the year ended December 31, 2025). That is 21.4% higher than the $90.40M of fiscal 2024.

What is the growth rate of UroGen Pharma Ltd.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 56.2% a year.

What are the highest and lowest revenue figures on record for UroGen Pharma Ltd.?

Across the 10 fiscal years on record (2016–2025), the highest was $109.79M in fiscal 2025 and the lowest $18.00K in fiscal 2019.

How is UroGen Pharma Ltd.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For UroGen Pharma Ltd. it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “UroGen Pharma Ltd. (URGN) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/URGN/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.